Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.37 | 12.31 |
PEG Ratio (TTM) | -0.05 | 4.15 |
P/S Ratio (TTM) | 0.06 | 1.41 |
P/B Ratio (TTM) | 1.51 | -11.09 |
P/FCF Ratio (TTM) | -0.62 | 18.74 |
Price to 5YR AVG Earnings Ratio | N/A | 19.19 |
Price to 5YR AVG FCF Ratio | N/A | 22.96 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -35.26% | 5.31% |
ROE (TTM) | -176.71% | -84.46% |
Net Profit Margin (TTM) | -16.67% | 0.50% |
ROIC 5YR AVG | N/A | 16.46% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 6.15% | -131.95% | N/A |
Revenue | 5.10% | 22.09% | N/A |
Net Income | 1.65% | -144.76% | N/A |
Cash Flow | -37.05% | -2,217.30% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.49 | 1.36 |
Quick Ratio (TTM) | 2.27 | 1.25 |
D/E Ratio (TTM) | 5.91 | -5.53 |
Interest Coverage (TTM) | -7.68 | 5.41 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | 0.04 | 2.91 |
LTL to 5YR AVG FCF | N/A | 7.97 |
Shares Outstanding Growth 5YR AVG | N/A | -0.44% |